| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Increases phenotype | PMID:31154016; PMID:31276768; PMID:31678613 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Increases phenotype | PMID:30763683; PMID:39117293 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:38546835 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:31276768 |
| GO:0000280 | Nuclear division | Decreases phenotype | PMID:37162024 |
| GO:0000422 | Autophagy of mitochondrion | Increases phenotype | PMID:24755393 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:39117293 |
| GO:0001765 | Membrane raft assembly | Decreases phenotype | PMID:34101318 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:24792326 |
| GO:0001819 | Positive regulation of cytokine production | Increases phenotype | PMID:28935500 |
| GO:0002522 | Leukocyte migration involved in immune response | Increases phenotype | PMID:36227364 |
| GO:0002537 | Nitric oxide production involved in inflammatory response | Increases phenotype | PMID:25532488 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:28935500 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:36227364 |
| GO:0004364 | Glutathione transferase activity | Increases phenotype | PMID:37633472 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:27923682 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:26861962; PMID:27923682; PMID:36397609 |
| GO:0005978 | Glycogen biosynthetic process | Increases phenotype | PMID:27923682 |
| GO:0006099 | Tricarboxylic acid cycle | Decreases phenotype | PMID:32835834 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:27923682 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:34101318; PMID:38896176; PMID:39053875 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:30291945 |
| GO:0006754 | Atp biosynthetic process | Affects phenotype | PMID:27597255; PMID:30876885 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:27597255; PMID:34748853 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:24755393 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:20108032; PMID:24120684; PMID:25002221; PMID:25002221; PMID:32617660; PMID:30120945; PMID:30763683; PMID:31154016; PMID:33465424; PMID:37162024; PMID:38546835; PMID:39947449 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:32617660; PMID:33543323 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:24525463; PMID:27193732; PMID:30120945 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:11701387 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:38546835 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:27923682; PMID:32468156 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:27923682 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:34126166 |
| GO:0008219 | Cell death | Increases phenotype | PMID:1987662; PMID:26505656; PMID:26861962; PMID:26505656; PMID:27153755; PMID:26861962; PMID:27153755; PMID:28710020; PMID:30428381; PMID:30428381; PMID:31678613; PMID:31678613; PMID:32905824 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:23172667; PMID:24120684; PMID:25002221; PMID:28286205; PMID:29126803; PMID:31154016; PMID:31276768; PMID:31678613 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:38301995 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30559759; PMID:32835834; PMID:34101318 |
| GO:0008360 | Regulation of cell shape | Affects phenotype | PMID:28286205; PMID:29673704 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:27422291; PMID:39299375 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25532488; PMID:27422291; PMID:28951292 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:27923682; PMID:30291945 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30120945; PMID:30291945; PMID:30716354 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:31276768 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:25532488 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:39053875 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:27923682 |
| GO:0031323 | Regulation of cellular metabolic process | Affects phenotype | PMID:30559759 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:32910239; PMID:38301995; PMID:39947449 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:34101318 |
| GO:0032964 | Collagen biosynthetic process | Increases phenotype | PMID:25091173 |
| GO:0032967 | Positive regulation of collagen biosynthetic process | Increases phenotype | PMID:27422291 |
| GO:0034263 | Positive regulation of autophagy in response to er overload | Increases phenotype | PMID:36058351 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:25532488; PMID:34101318; PMID:38546835; PMID:38896176; PMID:39053875 |
| GO:0035265 | Organ growth | Decreases phenotype | PMID:28321044 |
| GO:0036444 | Calcium import into the mitochondrion | Increases phenotype | PMID:31154016 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:34101318 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:27422291; PMID:34101318; PMID:36058351 |
| GO:0043553 | Negative regulation of phosphatidylinositol 3-kinase activity | Increases phenotype | PMID:34101318 |
| GO:0043970 | Histone h3-k9 acetylation | Affects phenotype | PMID:29098329 |
| GO:0043971 | Histone h3-k18 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043972 | Histone h3-k23 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043974 | Histone h3-k27 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043977 | Histone h2a-k5 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043980 | Histone h2b-k12 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043981 | Histone h4-k5 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043982 | Histone h4-k8 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043983 | Histone h4-k12 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0043984 | Histone h4-k16 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0044154 | Histone h3-k14 acetylation | Decreases phenotype | PMID:29098329 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:31276768; PMID:31678613; PMID:31678613; PMID:32659470; PMID:34481902; PMID:32617660; PMID:36587836; PMID:32659470; PMID:33465424; PMID:34126166; PMID:34748853; PMID:36587836; PMID:38896176 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:31154016; PMID:31276768; PMID:31678613; PMID:39117293 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:1987662 |
| GO:0045627 | Positive regulation of t-helper 1 cell differentiation | Increases phenotype | PMID:28935500 |
| GO:0045786 | Negative regulation of cell cycle | Increases phenotype | PMID:36058351 |
| GO:0045821 | Positive regulation of glycolytic process | Increases phenotype | PMID:32835834 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:24525463; PMID:28286205; PMID:30428381; PMID:30763683; PMID:31154016; PMID:31678613 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:34126166; PMID:34126166; PMID:38546835; PMID:39053875; PMID:38546835; PMID:39053875; PMID:39053875 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:11701387; PMID:1987662 |
| GO:0046622 | Positive regulation of organ growth | Decreases phenotype | PMID:24243707 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:39299375 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:26861962; PMID:27193732; PMID:27597255; PMID:31154016; PMID:31678613; PMID:31678613; PMID:34481902 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:39053875 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:31154016 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:26314263 |
| GO:0070062 | Extracellular exosome | Increases phenotype | PMID:34481902 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:29126803; PMID:32468156; PMID:36227364; PMID:39053875; PMID:39947449 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:38546835 |
| GO:0070269 | Pyroptosis | Increases phenotype | PMID:33543323 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:27346841; PMID:27597255; PMID:38546835 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:25218026; PMID:34015425; PMID:34481902; PMID:34748853; PMID:36587836; PMID:39947449 |
| GO:0090156 | Cellular sphingolipid homeostasis | Decreases phenotype | PMID:34101318 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:28286205 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:39299375 |
| GO:1900103 | Positive regulation of endoplasmic reticulum unfolded protein response | Increases phenotype | PMID:36058351 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:32835834 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:34101318; PMID:39299375 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:25532488 |
| GO:1901987 | Regulation of cell cycle phase transition | Affects phenotype | PMID:37633472 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:39117293 |
| GO:1903209 | Positive regulation of oxidative stress-induced cell death | Increases phenotype | PMID:35543154 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Decreases phenotype | PMID:25532488 |
| GO:1903303 | Negative regulation of pyruvate kinase activity | Increases phenotype | PMID:32835834 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:26861962; PMID:28286205; PMID:30120945; PMID:30291945; PMID:31678613 |
| GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:37633472 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:34101318; PMID:35543154; PMID:38812125 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:38812125; PMID:39299375 |
| GO:1905168 | Positive regulation of double-strand break repair via homologous recombination | Increases phenotype | PMID:24243707 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:34481902 |
| GO:2000615 | Regulation of histone h3-k9 acetylation | Affects phenotype | PMID:30559759 |
| GO:2000616 | Negative regulation of histone h3-k9 acetylation | Increases phenotype | PMID:30559759 |
| GO:2000617 | Positive regulation of histone h3-k9 acetylation | Increases phenotype | PMID:30559759 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.